SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

ELTX

Elicio Therapeutics Inc.
NASDAQHealth Care

Latest close: 1.56 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Sep 14, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Aug 13, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
  3. Aug 13, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record3438 flagged findings
Reported transactions (Form 4)49since Dec 22, 2023 · and 36 other holdings
Corporate events (8-K)30since Jan 17, 2023

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

Identity

Formerly traded as ANGN.

Reverse splits in 5 years

1 reverse split in 5 years (1:10 on Jun 2, 2023) · 1:10 cumulative

The other times: of 818 securities that did their first reverse split in 5 years, a year later the median was worth 0.53× the price on the day of the split; 382 lost more than half and 209 rose (809 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 343)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 9, 26DEF 14A ↗Shareholder meeting and votes
  • Sep 14, 268-K ↗Current report · Board nominations · Other events
  • Insider transaction · 7 Form 4 filingsshow all 7hide
  • Aug 13, 2610-Q ↗Quarterly report
  • Aug 13, 268-K ↗Current report · Results
  • Insider transaction · 4 Form 4 filingsshow all 4hide
  • Jul 16, 26SCHEDULE 13G ↗Passive stake · Moti Investments LLC · 6.1% · event on Jul 1, 26
  • Jul 8, 26SCHEDULE 13G/A ↗Passive stake · Knoll Capital Management, LLC · 5.3% · event on Jul 1, 26 · amendment
  • Jul 2, 26424B5 ↗Securities offering
  • Jul 2, 268-K ↗Current report · Entered a material agreement
  • Jun 24, 268-K ↗Current report · Communication to the market
  • Jun 17, 268-K ↗Current report · Other events
  • Jun 15, 268-K ↗Current report · Other events
  • May 11, 2610-Q ↗Quarterly report
  • May 11, 268-K ↗Current report · Results
  • Apr 29, 2610-K/A ↗Annual report · amendment

343 filings on record, the oldest from Apr 14, 14.

Listing the 25 most recent filings of the 343 on record.

8-Ks, explained

Stress3Structure22Governance14
  • Jul 2, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Mar 16, 26StructureA material agreement was terminated+1 more in the same filing8-K 1.02 ↗
  • Jun 4, 25StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
  • Mar 24, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Mar 5, 25StructureSold unregistered shares8-K 3.02 ↗
  • Jan 30, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Oct 17, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Aug 30, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Structure3 material agreements entered2024show all 3hide
    • Aug 12, 24StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
    • Jul 1, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Mar 18, 24StructureEntered a material agreement8-K 1.01 ↗
  • Feb 2, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Dec 22, 23StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Governance3 senior executive changes2023show all 3hide
    • Oct 20, 23GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Oct 12, 23GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Aug 30, 23GovernanceA senior executive left or was appointed8-K 5.02 ↗

3 older filings not shown · The record reaches back to Feb 9, 21.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • Dec 22, 22StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Jul 25, 22StressRestructuring plan with committed costs+1 more in the same filing8-K 2.05 ↗
  • Jan 4, 22StressRestructuring plan with committed costs+1 more in the same filing8-K 2.05 ↗

The full record holds 3 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • Yekaterina Chudnovsky48.1%Mar 5, 25SCHEDULE 13D/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • GKCC, LLC48.0%Jun 3, 25SCHEDULE 13D/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Moti Investments LLC6.1%Jul 1, 26SCHEDULE 13G ↗
  • Knoll Capital Management, LLC5.3%Jul 1, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Actyus Private Equity SGIIC, S.A.1.6%Sep 30, 25SCHEDULE 13G/A ↗2 earlier filings

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Dec 22, 23Buy$7.0MYekaterina Chudnovsky↗
Stock compensation, tax and giftsshow the 8 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Feb 2, 26Compensationamount n/aChristopher HaqqSee Remarks↗
  • Feb 2, 26Compensationamount n/aPeter DeMuthChief Scientific Officer↗
  • Feb 2, 26Compensationamount n/aPreetam ShahSee Remarks↗
  • Feb 2, 26Compensationamount n/aRobert ConnellyCEO, President and Director↗
  • Dec 9, 25Compensation$2KPeter DeMuthChief Scientific Officer↗
  • Mar 5, 25Other$20.3MYekaterina Chudnovsky↗
  • Dec 16, 24Compensation$2KPeter DeMuthChief Scientific Officer↗
  • Nov 26, 24Other$500Jay Venkatesan↗

The full record holds 9 transactions and goes back to Jun 1, 23.

Its sector and its market

Elicio Therapeutics Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Elicio Therapeutics Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Elicio Therapeutics Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
343 documents on file, from Apr 14, 2014 to Oct 9, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.

Elicio Therapeutics Inc. (ELTX): stock price history, insider trades and SEC filings — HornScout